The Rs 18,000 crore share buyback of TCS will kick off today and the company will continue to accept shares till March 23. It plans to buy ...

Under the terms of the agreement, Sentynl will acquire global rights to Nulibry and will be responsible for the ongoing development and com...

India’s drug regulator has not cleared the application of Dr Reddy’s Laboratories seeking approval to market the Sputnik V Covid-19 vaccine...

The two funds together hold a 23% stake and the remainder is with the Daftary family.

The portfolio of acute, chronic and oncology products could fetch a valuation of $1.5-2 bn, making it among the largest outbound transactio...

With a doctoral degree from University of Sunderland, Sharvil is the third generation Patel to lead Cadila. The company was founded by his ...

As part of the agreement, AZ will sell the following brands of Bricarex, Bricarex-A, Bricanyl, Xylocard, Ceriviprime, Prostodin, Partocin a...

"It gains access to the specialty distribution network and a large prescriber base....This acquisition will also enable the Zydus group to ...

Sentynl acquires, develops and commercialises prescription products, according to the company's website. It holds rights for opioid-based d...